Clinical Trials Logo

Filter by:
NCT ID: NCT03782402 Terminated - Clinical trials for Chemotherapy-induced Peripheral Neuropathy

Cannabinoids for Taxane Induced Peripheral Neuropathy

Start date: September 1, 2019
Phase: Phase 2
Study type: Interventional

Taxane-induced peripheral neuropathy (TIPN) affects a significant number of women undergoing breast cancer treatment. Some patients may need to shorten their course of treatment, and do not receive the full benefit of chemotherapy as a result. Rodent studies have shown that the cannabinoids may significantly improve hyperalgesia and allodynia induced by paclitaxel. The goal of this study is to investigate the cannabinoids THC and CBD for TIPN.

NCT ID: NCT03782168 Terminated - Abruptio Placentae Clinical Trials

Plasma Concentration of Biological Markers in Placental Abruption

Start date: January 31, 2019
Phase:
Study type: Observational

This will be a prospective study conducted on women with a suspected/confirmed diagnosis of placental abruption. Maternal blood samples will be taken at various points during the peripartum period. A healthy group of women admitted for delivery will act as a matched control and will have their blood sampled at similar time points. The primary outcome variables will include the total number of micro-particles, the number of micro-particles from each cell line (platelet, placental, endothelial etc.), and protein markers (specifically; placental growth factor (PlGF), soluble fms-like tyrosine kinase-1 (sFLT-1), vascular endothelial growth factor (VEGF), soluble endoglin (sEng)). Secondary outcomes if will examine the correlation between placental micro-particles, biomarkers, and extent of placental abruption.

NCT ID: NCT03782064 Terminated - Multiple Myeloma Clinical Trials

Dendritic Cell (DC)/Myeloma Fusions in Combination With Nivolumab in Patients With Relapsed Multiple Myeloma

Start date: February 22, 2019
Phase: Phase 2
Study type: Interventional

This research study is studying a cancer vaccine called Dendritic Cell/MM Fusion vaccine (DC/MM vaccine) in combination with nivolumab, as a possible treatment for multiple myeloma (MM). The drugs involved in this study are: - Dendritic Cell/MM Fusion vaccine (DC/MM vaccine) - Nivolumab, an immunotherapy drug

NCT ID: NCT03781960 Terminated - Clinical trials for Hepatocellular Carcinoma

Abemaciclib and Nivolumab for Subjects With Hepatocellular Carcinoma

Start date: July 31, 2019
Phase: Phase 2
Study type: Interventional

The main purpose of this study is to evaluate the effectiveness of the combination of nivolumab and abemaciclib for the treatment of hepatocellular carcinoma. Other goals of this study are to learn about the side effects that this combination of drugs may cause and to learn more about how these drugs work by studying blood and tissue.

NCT ID: NCT03781817 Terminated - Trauma Clinical Trials

Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children With Non-operative Fractures

Start date: September 9, 2019
Phase: Phase 4
Study type: Interventional

This a randomized clinical trial involving children with non-operative fractures presenting the emergency department randomized either to intranasal or intravenous ketamine.

NCT ID: NCT03781778 Terminated - Rectal Cancer Clinical Trials

Pilot Trial of Resistant Starch in Stage I-III Colorectal Cancer Survivors

Start date: May 7, 2019
Phase: Phase 2
Study type: Interventional

This phase II, randomized pilot trial studies the effect of the consumption of foods made with resistant starch compared to foods made with corn starch on biomarkers that may be related to colorectal cancer progression in stage I-III colorectal cancer survivors. Foods made with resistant starch may beneficially influence markers of inflammation, insulin resistance, and the composition of gut bacteria in colorectal cancer survivors.

NCT ID: NCT03780543 Terminated - Chronic Hepatitis B Clinical Trials

A Study of ABI-H0731 + Nucleos(t)Ide as Finite Treatment for Chronic Hepatitis B Patients

Start date: December 20, 2018
Phase: Phase 2
Study type: Interventional

Open-label, extension study to evaluate the safety and efficacy of combination therapy and its effect on sustained viral response biomarkers.

NCT ID: NCT03780387 Terminated - Asthma Atopic Clinical Trials

Identification of Allergic Asthmatics Reactive to Felis Catus (Cat Hair) Allergen Inhalation

Start date: April 16, 2019
Phase: Early Phase 1
Study type: Interventional

This study is designed to identify Felis Catus, or cat hair, sensitive asthmatics who demonstrate a late phase asthmatic response after cat hair inhalation. These subjects may be invited to participate in a planned future study investigating novel asthma treatments.

NCT ID: NCT03780205 Terminated - Amblyopia Clinical Trials

Bilateral and Unilateral Amblyopia Treatment Study

Start date: March 20, 2019
Phase:
Study type: Observational

The purpose for this study is to investigate spectacle compliance and treatment outcome in bilateral and unilateral refractive amblyopia in children age 3 to <10 years old. Specifically, how frequently and for what duration is spectacle wear necessary to maximize best-corrected visual acuity by spectacle correction alone.

NCT ID: NCT03779555 Terminated - Multiple Myeloma Clinical Trials

Lenalidomide Adherence in Older Adults

Start date: December 13, 2019
Phase:
Study type: Observational

To describe patterns of adherence and pilot baseline measures to investigate factors associated with lower adherence to lenalidomide in older adults with myeloma.